134 related articles for article (PubMed ID: 26292711)
1. Survival trends in T cell prolymphocytic leukemia: A SEER database analysis.
Chandran R; Gardiner SK; Fenske TS; Spurgeon ES
Leuk Lymphoma; 2016; 57(4):942-4. PubMed ID: 26292711
[No Abstract] [Full Text] [Related]
2. Where do we currently stand with T-cell prolymphocytic leukemia?
Khot A
Leuk Lymphoma; 2019 Mar; 60(3):563-565. PubMed ID: 30668215
[No Abstract] [Full Text] [Related]
3. Characteristics and survival outcomes of patients with T cell prolymphocytic leukemia in the United States: 2011-2020 analysis of the SEER database.
Wasifuddin M; Ilerhunmwuwa NP; Becerra H; Wang JC
Leuk Lymphoma; 2023 Dec; 64(12):2051-2053. PubMed ID: 37531079
[No Abstract] [Full Text] [Related]
4. Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Drozd-Sokolowska J; Gras L; Koster L; Martino R; Salas MQ; Salmenniemi U; Zudaire T; Yañez L; Bellido M; Collin M; Kaufmann M; Kozlowski P; Poiré X; Ferra C; Sampol A; Wilson KMO; Cairoli A; Gedde-Dahl T; Deconinck E; Mirabile M; Suarez F; Raj K; Van Gelder M; Yakoub-Agha I; Tournilhac O; McLornan DP
Haematologica; 2024 May; 109(5):1608-1613. PubMed ID: 38205539
[No Abstract] [Full Text] [Related]
5. T-cell Prolymphocytic Leukemia.
Sud A; Dearden C
Hematol Oncol Clin North Am; 2017 Apr; 31(2):273-283. PubMed ID: 28340878
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
[TBL] [Abstract][Full Text] [Related]
7. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
[TBL] [Abstract][Full Text] [Related]
8. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
[TBL] [Abstract][Full Text] [Related]
9. T-cell prolymphocytic leukemia presenting as ascites.
Hermans SJF; Sandberg Y
Blood; 2019 Jul; 134(4):411. PubMed ID: 31345928
[No Abstract] [Full Text] [Related]
10. T-cell prolymphocytic leukemia.
Dearden CE
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S239-43. PubMed ID: 19778847
[TBL] [Abstract][Full Text] [Related]
11. Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center Experience.
Damlaj M; Sulai NH; Oliveira JL; Ketterling RP; Hashmi S; Witzig T; Nowakowski G; Call TG; Shanafelt TD; Ding W; Hogan WJ; Litzow MR; Patnaik MM
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):699-704. PubMed ID: 26422251
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
Guillaume T; Beguin Y; Tabrizi R; Nguyen S; Blaise D; Deconinck E; Redjoul R; Cornillon J; Guillerm G; Contentin N; Sirvent A; Turlure P; Salmon A; Huynh A; François S; Peffault de Latour R; Yakoub-Agha I; Mohty M
Eur J Haematol; 2015 Mar; 94(3):265-9. PubMed ID: 25130897
[TBL] [Abstract][Full Text] [Related]
13. Extreme hyperlymphocytosis.
Berz D; Freeman NJ
J Clin Oncol; 2008 Feb; 26(4):674-5. PubMed ID: 18235128
[No Abstract] [Full Text] [Related]
14. Recurrent infection in a patient with chronic neutropenia.
Litam PP; Loughran TP
Hosp Pract (Off Ed); 1995 Feb; 30(2):117-8. PubMed ID: 7852460
[No Abstract] [Full Text] [Related]
15. T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.
Hsi AC; Robirds DH; Luo J; Kreisel FH; Frater JL; Nguyen TT
Am J Surg Pathol; 2014 Nov; 38(11):1468-83. PubMed ID: 25310835
[TBL] [Abstract][Full Text] [Related]
16. [Chronic T-cell lymphatic leukemia].
Rossetti A; Bonati PL; Zannoni M; Sansoni P
G Clin Med; 1990 Oct; 71(10):593-9, 602-6. PubMed ID: 2289655
[No Abstract] [Full Text] [Related]
17. A pediatric case of T-cell prolymphocytic leukemia.
Mitton B; Coutre S; Willert J; Schlis K; Porteus M; Kharbanda S; Agarwal-Hashmi R
Pediatr Blood Cancer; 2015 Jun; 62(6):1061-2. PubMed ID: 25417638
[TBL] [Abstract][Full Text] [Related]
18. [T-cell prolymphocytic leukemia revealed by spinal cord compression].
Haouach K; Tazi I; Mahmal L
Ann Biol Clin (Paris); 2013; 71(2):181-4. PubMed ID: 23587583
[TBL] [Abstract][Full Text] [Related]
19. T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.
Vardell VA; Ermann DA; Fitzgerald L; Shah H; Hu B; Stephens DM
Am J Hematol; 2024 Mar; 99(3):494-496. PubMed ID: 38240336
[TBL] [Abstract][Full Text] [Related]
20. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
Cao TM; Coutre SE
Hematology; 2003 Feb; 8(1):1-6. PubMed ID: 12623420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
